Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 33% | 8.2% | 15.1% |
| Success rate | 99% | 68% | 82% |
| Transactions |
8
38% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Independent Director | Establishment Labs Holdings Inc | Jan. 1, 2016 - |
| Independent Director | Novocure Ltd | May 31, 2018 - |
| Chief Executive Officer, Director | Axovant Gene Therapies Ltd | April 7, 2017 - Feb. 12, 2018 |
| President, Chief Executive Officer, Director | Medivation Inc | Dec. 17, 2004 - Sept. 28, 2016 |
Search